We initially used gross histological assessment of immune infiltrate and distribution using the Salgado scoring system [27] in 31 primary OCCC tumours (Figure 1) and correlated TILs with FIGO tumour stage, clinical risk status and ARID1A mutation status (Supplementary Table S5). The gene discussed is ARID1A; the disease is neoplasm.